Insiders Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 05/12/2025 GMT			5-day change	1st Jan Change
309.60 ^DKK	+1.24%		-2.33%	-50.40%

12-05	Sector Update: Health Care Stocks Lower Late Afternoon	MT
12-05	Sector Update: Health Care Stocks Decline Friday Afternoon	MT

Insiders

PRESS DIGEST-Canada - Dec 2	12-02	RE
Lilly Cuts Prices for Cash Buyers of Weight-Loss Drug Zepbound	12-01	MT
Novo's Ozempic Pill Fails in Alzheimer's Effort	11-24	MT
Novo Nordisk says Alzheimer's drug trial fails, hammering shares	11-24	RE
Novo's Ozempic Pill Fails to Slow Alzheimer's in Studies	11-24	MT
Hims & Hers names ex-FDA official Deb Autor as first policy chief	11-17	RE
Novo Nordisk Elects New Chair, Vice Chair	11-14	MT
Novo Nordisk A/S Approves Board Members	11-14	CI
Novo Nordisk Shareholders Approve New Chair, Board Members -- Update	11-14	DJ
Novo Nordisk Elects New Chair, Vice Chair in Board Shakeup	11-14	MT
Novo Nordisk Shareholders Approve New Chair, Board Members	11-14	DJ
Novo Nordisk chair touts OTC future for Wegovy as top investor tightens grip	11-14	RE
Novo Nordisk Says Mikael Dolsten Won't Seek Election to Board at Friday's Meeting	11-14	DJ
Pfizer's former R&D chief Dolsten pulls out of Novo Nordisk board race	11-13	RE
Novo Nordisk A/S Announces Mikael Dolsten Will Not Seek Election as Board of Director	11-13	CI
'Not been pretty': Novo Nordisk faces rare shareholder rebuke over board shake-up	11-13	RE
Global markets live: Rumble, Tesla, Instacart, Pfizer, Diageo…	11-10
Norway's Wealth Fund to Abstain from Voting on Novo Nordisk's Board Changes	11-10	MT
Norway's Oil Fund to Abstain From Novo Nordisk Board Vote	11-10	DJ
Novo, Pfizer Boost Metsera Bids in Obesity Startup Battle	11-04	MT
Barclays Says Novo Nordisk's Board Overhaul Shows 'Push for Faster Execution' Amid Competition	10-23	MT
Novo Nordisk Shares Fall Premarket; Chair Lund, 6 Directors Won't Stand for Re-Election at Extra Meeting	10-22	MT
PRESS DIGEST-Financial Times - October 22	10-22	RE
Novo Nordisk's top investor seizes board control in weight-loss drug battle	10-21	RE
Who's on Novo Nordisk's board after major shakeup?	10-21	RE